"Sub is a weird drug:" A web-based study of lay attitudes about use of buprenorphine to self-treat opioid withdrawal symptoms.

BACKGROUND Illicit use of buprenorphine has increased in the U.S., but our understanding of its use remains limited. This study aims to explore Web-forum discussions about the use of buprenorphine to self-treat opioid withdrawal symptoms. METHODS PREDOSE, a novel Semantic Web platform, was used to extract relevant posts from a Web-forum that allows free discussions on illicit drugs. First, we extract information about the total number of buprenorphine-related posts per year between 2005 and 2013. Second, PREDOSE was used to identify all posts that potentially contained discussions about buprenorphine and opioid withdrawal. A total number of 1,217 posts that contained these terms were extracted and entered into NVivo data base. A random sample of 404 (33%) posts was selected and content analyzed. RESULTS Buprenorphine-related posts increased over time, peaking in 2011. The posts were about equally divided between those that expressed positive and negative views about the effectiveness of buprenorphine in relieving withdrawal symptoms. Web-forum participants emphasized that buprenorphine's effectiveness may become compromised because of the "size of a person habit," and/or when users repeatedly switch back and forth between buprenorphine and other illicit opioids. Most posts reported use of significantly lower amounts of buprenorphine (≤2 mg) than doses used in standard treatment. Concomitant use of other psychoactive substances was also commonly reported, which may present significant health risks. CONCLUSIONS Our findings highlight the usefulness of Web-based data in drug abuse research and add new information about lay beliefs about buprenorphine that may help inform prevention and policy measures.

[1]  A. Kleinman,et al.  Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. , 1978, Annals of internal medicine.

[2]  Kimberly A. Neuendorf,et al.  Reliability for Content Analysis , 2010 .

[3]  Amit P. Sheth,et al.  PREDOSE: A semantic web platform for drug abuse epidemiology using social media , 2013, J. Biomed. Informatics.

[4]  Jeffrey J. Annon,et al.  A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. , 2005, Addiction.

[5]  J. Rich,et al.  Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review. , 2011, Current drug abuse reviews.

[6]  N. Dasgupta,et al.  OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION Original Research Article Post-marketing Surveillance of Methadone and Buprenorphine in the United States , 2010 .

[7]  Fabrizio Schifano,et al.  e-Psychonauts: Conducting research in online drug forum communities , 2012, Journal of mental health.

[8]  L. Amass,et al.  Buprenorphine: how to use it right. , 2003, Drug and alcohol dependence.

[9]  Lyle H. Ungar,et al.  Identifying potential adverse effects using the web: A new approach to medical hypothesis generation , 2011, J. Biomed. Informatics.

[10]  J. Havens,et al.  Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine. , 2012, Drug and alcohol dependence.

[11]  M. McHugh Interrater reliability: the kappa statistic , 2012, Biochemia medica.

[12]  A. Bruckman Studying the amateur artist: A perspective on disguising data collected in human subjects research on the Internet , 2002, Ethics and Information Technology.

[13]  Raminta Daniulaityte,et al.  Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids. , 2012, Drug and alcohol dependence.

[14]  Sujan Perera,et al.  "I just wanted to tell you that loperamide WILL WORK": a web-based study of extra-medical use of loperamide. , 2013, Drug and alcohol dependence.

[15]  Greta Kilmer,et al.  The DAWN report: Emergency department visits involving buprenorphine , 2012 .

[16]  Fabrizio Schifano,et al.  Drugs on the web; the Psychonaut 2002 EU project , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  P. Miller,et al.  Using the internet to research hidden populations of illicit drug users: a review. , 2010, Addiction.

[18]  D. Vlahov,et al.  Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland. , 2013, Addictive behaviors.

[19]  F. Sudweeks,et al.  Complementary Explorative Data Analysis: The Reconciliation of Quantitative and Qualitative Principles , 1999 .

[20]  G. Eysenbach Infodemiology and Infoveillance: Framework for an Emerging Set of Public Health Informatics Methods to Analyze Search, Communication and Publication Behavior on the Internet , 2009, Journal of medical Internet research.

[21]  H. Surratt,et al.  Effect of abuse-deterrent formulation of OxyContin. , 2012, The New England journal of medicine.

[22]  M. Heath,et al.  Psychological characteristics and the effectiveness of patient-controlled analgesia. , 1995, British journal of anaesthesia.

[23]  W. Ling,et al.  Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. , 2014, Addiction.

[24]  N. Mckeganey,et al.  Challenges of Reliability and Validity in the Identification and Monitoring of Emerging Drug Trends , 2010, Substance use & misuse.

[25]  E. Chiauzzi,et al.  Participatory Research With an Online Drug Forum: A Survey of User Characteristics, Information Sharing, and Harm Reduction Views , 2013, Substance use & misuse.

[26]  J. Rich,et al.  Illicit Use of Buprenorphine/Naloxone Among Injecting and Noninjecting Opioid Users , 2011, Journal of addiction medicine.

[27]  Dale L Kunkel,et al.  Media messages and public health: A decisions approach to content analysis , 2008 .

[28]  N. Brown,et al.  Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. , 2004 .

[29]  R P Mattick,et al.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. , 2008, The Cochrane database of systematic reviews.

[30]  Edward W Boyer,et al.  Diversion of Buprenorphine/Naloxone Coformulated Tablets in a Region with High Prescribing Prevalence , 2009, Journal of addictive diseases.

[31]  Edward W Boyer,et al.  Self-treatment of opioid withdrawal with a dietary supplement, Kratom. , 2007, The American journal on addictions.

[32]  Robert L DuPont,et al.  The Emerging Buprenorphine Epidemic in the United States , 2012, Journal of addictive diseases.

[33]  Sarah E. Nelson,et al.  Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers. , 2010, Journal of substance abuse treatment.

[34]  M. Agar Folks and professionals: different models for the interpretation of drug use. , 1985, The International journal of the addictions.

[35]  Richard L. Beaulaurier,et al.  Internet Surveillance: Content Analysis and Monitoring of Product-specific Internet Prescription Opioid Abuse-related Postings , 2007, The Clinical journal of pain.